Center Laboratories, Inc. (TPEX:4123)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
37.65
+0.10 (0.27%)
At close: Dec 5, 2025

Center Laboratories Company Description

Center Laboratories, Inc., a pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally.

The company offers general medication pharmaceuticals comprising antipyretics and analgesics, bronchodilators, anti-inflammatory preparations, antihistamines, expectorants, narcotic antitussives and expectorants, gastrointestinal preparations, non-narcotic antitussives and expectorants, and other medicines.

It also offers central nervous system medication consisting of treatments for cerebrovascular disease, dementia, depression, schizophrenia, epilepsy, and Parkinson's disease, as well as provides treatment for diabetes and pancreatic beta cells.

In addition, the company engages in drug development, cell therapy, biotechnology, hydrogen energy, and dairy business.

Center Laboratories, Inc. was founded in 1959 and is headquartered in Taipei City, Taiwan.

Center Laboratories, Inc.
Country Taiwan
Founded 1959
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
CEO Su-Chi Wang

Contact Details

Address:
No. 3-2, Building H
Taipei City, 115
Taiwan
Phone 886 2 2655 8680
Website centerlab.com.tw

Stock Details

Ticker Symbol 4123
Exchange Taipei Exchange
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency TWD
ISIN Number TW0004123005
SIC Code 2834

Key Executives

Name Position
Su-Chi Wang Chief Executive Officer, Chief Investment Officer, Chief Operating Officer and Chairman
An-Ni Mao Manager of Finance and Accounting Department
Hsiu Yueh Lin Director of Administration Department
Min-Li Lien Assistant Vice President of Legal Affairs Department
Jui-Pao Hsu General President of Pharmaceutical Business
Ching-Yu Tang Head of Corporate Governance
Chiun-Yu Lin Plant Director